{"name":"Adcendo ApS","slug":"adcendo-aps","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ADCE-T02","genericName":"ADCE-T02","slug":"adce-t02","indication":"Other","status":"phase_1"},{"name":"ADCE-B05","genericName":"ADCE-B05","slug":"adce-b05","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ADCE-T02","genericName":"ADCE-T02","slug":"adce-t02","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ADCE-B05","genericName":"ADCE-B05","slug":"adce-b05","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxQWnN4a2gxQmlnNm9TQTY1VzZZRDQ0UVJtOFM1cTc2a3ZsLUk2LW5yMDRTU05kOTNCdEViZmhBU1IwWUhhdzh0YlVGdHRfdXlzT1AwMWRoY1VVWXYzUTFyc1ZRY1VPRS1UeVVZLU5mdDM3Mi1PalNsTEp4SHM2YXlBRU5QQU9VdWFDaGtCdnJISl9vSlhIeEJ2bDB6N01EeV9Sa1hvb1JJTmNHYVFoVENsSlBpSFByV1ZiNXJfYUswRFduNGxrbXpWQWw4R3FlMElaOGtBOVd6elEzX0ZZU1lTQVBWbXpEeFdVdURwWV9RcFBSSTJMeFJLcw?oc=5","date":"2025-10-09","type":"regulatory","source":"PR Newswire","summary":"Adcendo ApS Announces FDA Fast Track Designation Granted to ADCE-D01 for the Treatment of Soft Tissue Sarcoma - PR Newswire","headline":"Adcendo ApS Announces FDA Fast Track Designation Granted to ADCE-D01 for the Treatment of Soft Tissue Sarcoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxPeFJHd1pDck9XV09PTjlqYldHNWtrNDJsS0NFTXJBcG9BRjJFc3ZHdDEtSmZsbjRmbzZMcGgzX0lyUFFFcV8xWnFnU0hvWFBSY3ViWFhmd1hFWUpHZ2hnSi1CVHBONHZlYmNUSUZoSzh3N092dmxfc1J6cTRfWjBlTlhqWVVBOWdwajRhekF2cmlJcjRtbVoyVy16U09tQlQ2dEV0c0ZjMi1udVFRbU9XZklaLTl2Y2RHZFZfV2E4NWV0VVlfVjZxSUdnMEo5TDNjVjBfZ2VXQ3VxUF9zemJFNVpkVUU3UDNRd3VRa1FFQUVZOWFLMkhjQzg1clRBOGdhTGV2bTFKNkZsdXVoYXJhcE9neHBJd2JwRnFzc3BRZXFHNmxQd2RwTklUVGZaUQ?oc=5","date":"2025-04-23","type":"trial","source":"PR Newswire","summary":"Adcendo ApS to Present Data on its Clinical Stage ADCs ADCE-T02 and ADCE-D01 at the 2025 American Association for Cancer Research (AACR) Annual Meeting - PR Newswire","headline":"Adcendo ApS to Present Data on its Clinical Stage ADCs ADCE-T02 and ADCE-D01 at the 2025 American Association for Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNNkV0S1dCMDVxeHUwRncweHl4Rm1IMTFleVIyemdPcXYtMy0wZlEzaktIRW9EcVVZOG42V0RWXzl0VWRkM3U5ZEs0WDJPNG9ZcHVLZjBfR0VsMkQ4TDhxTGYxWUJ4dXNYUHJHRWV1UEFwOWxfVlFVekFDcjlnam1FcTR3M2lwYzZjR2g3eUsxaVlpa0hxZi1GOXpqeDBMenN4WHIwdDV5UmVPTFcxeDNoLWt4SzdKdXZxSG9xQXJuVlo0R1kwTy1iOFpYZGNNSEVyMDh5dS1wV2xnVmVLdklic2M0TVBVUFBnSlE?oc=5","date":"2025-02-26","type":"regulatory","source":"PR Newswire","summary":"Adcendo ApS Announces U.S. FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02 - PR Newswire","headline":"Adcendo ApS Announces U.S. FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxQdlM2b3ZmN1Q0X3loazA0SkxrUWJDd3NBYzczYV9rV1Z1c243R1NDbkh0RHd4VFFmX3BRYkFmT2NLZ2RJTzdMWWlTODlLZk04TFNRdkI2QzlCLTdyaWs0SHRySkNpanpRNzRvT2ZBYUJhZWtpcUtTZmE2RGNNT2Q4NThrSnl2WEp0bXR1d09mYlZPYWpzXzdHY1ptSGJYRmY2LWt6WEZEZVM1UDR6N1pITmV1ZjZXMGJwV2o1TDFxR2Y4V3VicExJQTVXTTlhMHVlZ1p1SjByQVFjWnlKejlEdFRaVDNnUEN4dTFNN2hrSF9FcGJJT0VFcWVmbEN5eXY2OWNvVTI2QTQ?oc=5","date":"2024-11-25","type":"deal","source":"PR Newswire","summary":"Duality Biologics Announces Expansion of Adcendo ApS Collaboration Through Option Exercise of Strategic License Agreement - PR Newswire","headline":"Duality Biologics Announces Expansion of Adcendo ApS Collaboration Through Option Exercise of Strategic License Agreemen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxPVkFpVFUwWXRoOUxqTk04NFdPS3VxRmc4U1FEUG1UMGpqaHYzaUNzSk5tNGw2MmZRVl9NZVJKd296Tk9aX1lEQ0thWXNoc1Y3WUpjZ1hEQkd0Nl9CakIzYTBDX0M4TTBSSTU4NGcyZVJ5Q08zTmttLTRWM3FQekNINmY4bXQxU2JzSnBGalNaejBHd3g3eHpxYTZEbGVNeHVBaTV1TzRCY1pNbTR4M0RIek9xVUtBc0lkMDVQNl9XSGdxX09yQUZjVlVtU1BMam5yTkZjVmVEaEpYZTRndFh0TmtZTURyQXVkV01GVzhmRGRORVFD?oc=5","date":"2024-11-25","type":"pipeline","source":"PR Newswire","summary":"Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline - PR Newswire","headline":"Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNQUVmemlDV25CRzU0ZXFKaXFvYzNHR3RGOHdsb3AtNk5XVlM2T0tmSTdHWDhHcjRLWDRYcG4zRXpwNS1rQm16YWhqMFVrSzlzb2VtRERtZkh6eHRtOUJ3WGYxcDN1cUh4b19ZRzdiSkpNLUhGTlc0eXZqbTZRVWMyZXQ2aTdtdDJJVHZ2Z18yeE0ydkdDSHd4VlBGMEE3RWZOQXc?oc=5","date":"2024-08-20","type":"deal","source":"European Biotechnology Magazine","summary":"Adcendo broadens ADC pipeline in US$1bn biobucks deal - European Biotechnology Magazine","headline":"Adcendo broadens ADC pipeline in US$1bn biobucks deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQTkgtTUV5clJfWGNrUGFkY0VhX1h2Z3h2VE5XQVlnbkdSVDFUMDk2aFVzWDk4ZHZtVGtLS29ueUpWSzJkZGhGZzJQQWIzTXpoTWx2dTR1M1JiQUQ0Ml9zcHN5WUd4Qi1ZNkdVdExYaVBla1RObVN0YWUyR1VUMFFLN1FiSElUOG5xWlBnNS01cmNwUlQwVGlFRTFn?oc=5","date":"2024-07-11","type":"pipeline","source":"DCAT Value Chain Insights","summary":"The CDMO/CMO Report: Strong Growth Drives Contract ADC Market - DCAT Value Chain Insights","headline":"The CDMO/CMO Report: Strong Growth Drives Contract ADC Market","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}